ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Analyst Earnings Estimates
NASDAQ:ESLA - Nasdaq - US2975841048 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 402.53% | N/A 101.09% | N/A 50.64% | N/A 34.07% | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -250K | -1.685M -574.16% | -11.114M -559.45% | -7.31M 34.23% | N/A -220.09% | N/A -117.96% | N/A -40.00% | N/A 63.07% | N/A 1,128.29% | N/A 138.84% | N/A 58.60% | N/A 37.29% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A -63.04% | N/A -24.00% | N/A 66.67% | N/A 1,080.65% | N/A 128.29% | N/A 51.30% | N/A 29.14% |
All data in USD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.11 |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -5.569M -430.30% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.06 | -0.11 | 0.05 | 46.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |